Navigation

2004/005 People with chronic hepatitis C to benefit from guidance on new drugs and treatments

The National Institute for Clinical Excellence (NICE) has today (28 January 2004) issued guidance on the use of interferon alpha, peginterferon alfa - a newer, longer-acting version of interferon alfa, which doesn't need to be taken as often - and ribavirin for the treatment of chronic hepatitis C within the NHS in England and Wales.

This page was last updated: 29 April 2009

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.